Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ASENAPINE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for ASENAPINE SUBLINGUAL TABLETS. ASENAPINE sublingual tablets Initial U.S. Approval: 2009
Medication labelWhy this: Advisory · dailymed-prescription
Asenapine sublingual tablets are indicated for: Schizophrenia in adults [see Clinical Studies (14.1)] Bipolar I disorder [see Clinical Studies (14.2)] Acute monotherapy of manic or mixed episodes, in adults and pediatric patients 10 to 17 years of age Adjunctive treatment to lithium or valproate in adults Maintenance monotherapy treatment in adults
- generic_name
- asenapine maleate
- product_names
- ASENAPINE MALEATE
- ndc
- 51991-358, 51991-359, 51991-360, 51991-361, 51991-928, 51991-359-60, 51991-359-99, 51991-359-11, 51991-361-60, 51991-361-99, 51991-361-11, 51991-358-60, 51991-358-99, 51991-358-11, 51991-360-60, 51991-360-99, 51991-360-11, 51991-928-60, 51991-928-99, 51991-928-11
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en